article Open AccessTop 1% cited
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
Leukemia · 2016 · Vol. 30(5) · pp. 1044–1054
Andreas Hochhaus✉(Klinikum Magdeburg)Giuseppe Saglio(University of Turin)Timothy P. Hughes(South Australian Health and Medical Research Institute)Richard A. Larson(University of Chicago)D-W Kim(Catholic University of Korea)Surapol Issaragrisil(Siriraj Hospital)Philipp D. le Coutre(Charité - Universitätsmedizin Berlin)Gabriel Étienne(Institut Bergonié)P.E. Dorlhiac‐Llacer(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo)Richard E. Clark(University of Liverpool)Ian W. Flinn(Sarah Cannon)Hirohisa Nakamae(Osaka City University)Breanne Donohue(Novartis (United States))Weiping Deng(Novartis (United States))Darshan Dalal(Novartis (United States))Hans D. Menssen(Novartis (Switzerland))Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center)
Chronic Myeloid Leukemia TreatmentsEosinophilic Disorders and SyndromesMyeloproliferative Neoplasms: Diagnosis and TreatmentNilotinibMedicineImatinibInternal medicineMyeloid leukemiaRandomized controlled trialImatinib mesylateOncologySurgery
MeSH terms
Imatinib MesylateBlood GlucoseCholesterolFollow-Up StudiesHumansPyrimidinesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, Chronic-PhaseTreatment OutcomeRisk Assessment
Funding
- Novartis Pharmaceuticals Corporation
Citations
845
FWCI
70.53
field-weighted impact
References
35
Percentile
100%
vs. same field & year
Citations per year
Cited by
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
Leukemia · 2016 · 470 citations
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Leukemia · 2020 · 1,470 citations
References
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Blood · 2013 · 1,979 citations
The National Comprehensive Cancer Network
Cancer · 1998 · 16,869 citations
Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61
Diabetes Care · 2011 · 3,067 citations
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
Circulation · 2013 · 7,098 citations
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
Leukemia · 2012 · 437 citations
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
Leukemia · 2012 · 416 citations
General Cardiovascular Risk Profile for Use in Primary Care
Circulation · 2008 · 7,326 citations
Standards of Medical Care in Diabetes—2011
Diabetes Care · 2010 · 2,882 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.